10 Best Pharma Stocks to Buy for Long Term Growth
With big American pharmaceutical corporations always searching for medications in China, the US pharmaceutical industry is going through a unique trend never seen before.
Posts Tagged ‘NASDAQ:SUPN’
10 Cash-Rich Small Cap Stocks To Invest In According To Analysts
Small-cap stocks in the US have been under pressure, with the Russell small cap index falling 10% from its November highs as of January 2025.
12 Best Small Cap Pharma Stocks to Buy Now
Emily Field, Head of European Pharma Research at Barclays, spoke on CNBC on February 20 about the performance of obesity medications, the effects of US tariffs, and the dynamics...
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2024 Earnings Call Transcript
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2024 Earnings Call Transcript February 25, 2025Supernus Pharmaceuticals, Inc. beats earnings expectations.
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q3 2024 Earnings Call Transcript
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q3 2024 Earnings Call Transcript November 4, 2024Supernus Pharmaceuticals, Inc. beats earnings expectations.
Supernus Pharmaceuticals (SUPN) Slid on Disappointing Progress Report on a Key Drug
Scout Investments, Inc, an affiliate of Carillon Tower Advisers, released the “Carillon Scout Small Cap Fund” second quarter 2024 investor letter.
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q2 2024 Earnings Call Transcript
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q2 2024 Earnings Call Transcript August 6, 2024Supernus Pharmaceuticals, Inc. misses on earnings expectations.
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q1 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Supernus Pharmaceuticals First Quarter 2024 Financial Results Conference Call.
Corporate Insiders Are Selling These 10 Small-Cap Stocks
In this article, we will take a detailed look at Corporate Insiders Are Selling These 10 Small-Cap Stocks. For a quick overview of such stocks, read our article Corporate Insiders...
11 Best Small Cap Pharma Stocks to Invest In
In this piece, we will take a look at the 11 best small cap pharma stocks to invest in.
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Supernus Pharmaceuticals' Fourth Quarter and Full Year 2023 Financial Results Conference Call.
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Supernus Pharmaceuticals Third Quarter 2023 Financial Results Conference Call.
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q2 2023 Earnings Call Transcript
Operator: Good afternoon and welcome to Supernus Pharmaceuticals Second Quarter 2023 Financial Results Conference Call. At this time, all participants are in listen-only mode.
5 Best Small Cap Pharma Stocks to Buy
In this piece, we will take a look at the five best small cap pharma stocks to buy.
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Supernus Pharmaceuticals First Quarter 2023 Financial Results Conference Call.
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, and welcome to Supernus Pharmaceuticals Fourth Quarter and Full Year 2022 Financial Results Conference Call.
Here’s Why Supernus Pharmaceuticals (SUPN) Outperformed in Q3
Scout Investments, an affiliate of Carillon Tower Advisers, an investment management company, released its “Carillon Scout Small Cap Fund” third quarter 2022 investor letter...
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q3 2022 Earnings Call Transcript
Operator: Good afternoon and welcome to Supernus Pharmaceuticals' Third Quarter 2022 Financial Results Conference Call.
5 Best Small-Cap Healthcare Stocks To Buy Now
In this article, we discuss 5 best small-cap healthcare stocks to buy now.
5 Best Pharmaceutical Stocks to Buy According to Steven Boyd’s Armistice Capital
In this article, we will take a look at some important pharma stock picks of Steven Boyd's Armistice Capital.
Here’s Why Third Avenue Management Invested in Supernus Pharmaceuticals (SUPN)
Third Avenue Management, an investment management company, released its “Small-Cap Value Fund” second quarter 2022 investor letter.
Should You Consider Investing in Supernus Pharmaceuticals (SUPN)?
WertArt Capital, an investment management firm, published its second-quarter 2021 investor letter – a copy of which can be downloaded here.
10 Cheap Healthcare Stocks To Buy Now
In this article we discuss 10 cheap healthcare stocks to buy now.
Is Supernus Pharmaceuticals Inc (SUPN) A Good Stock To Buy?
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file ...
Supernus Pharmaceuticals Inc (SUPN): Hedge Funds Are Snapping Up
In this article we will take a look at whether hedge funds think Supernus Pharmaceuticals Inc (NASDAQ:SUPN) is a good investment right now.
Were Hedge Funds Right About Supernus Pharmaceuticals Inc (SUPN)?
Hedge funds don't get the respect they used to get. Nowadays investors prefer passive funds over actively managed funds.
Do Hedge Funds Love Supernus Pharmaceuticals Inc (SUPN)?
Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying before last year's Q4 market crash that the stock market is overvalued due to a low interest...
Were Hedge Funds Right About Dumping Supernus Pharmaceuticals Inc (SUPN)?
The first quarter was a breeze as Powell pivoted, and China seemed eager to reach a deal with Trump.
Here’s What Hedge Funds Think About Supernus Pharmaceuticals Inc (SUPN)
Hedge funds are not perfect. They have their bad picks just like everyone else.
EA, Supernus Pharmaceuticals, and More: Stocks on the Move After Hours
It's been a busy Tuesday as usual and a lot of stocks such as Electronic Arts Inc.
Here’s What Hedge Funds Think About Supernus Pharmaceuticals Inc (SUPN)
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset...
Hedge Funds Aren’t Crazy About Supernus Pharmaceuticals Inc (SUPN) Anymore
"Market volatility has picked up again over the past few weeks.
Hedge Funds Are Crazy About Supernus Pharmaceuticals Inc (SUPN)
Looking for high-potential stocks? Just follow the big players within the hedge fund industry.
Here’s Why Supernus Pharmaceuticals, Rent-A-Center and Three Other Stocks are Down Today
Stocks are extending losses on Tuesday, mainly due to healthcare sector, which is down over 2%, and slipping crude prices.
Should You Buy Supernus Pharmaceuticals Inc (SUPN)?
Looking for high-potential stocks? Just follow the big players within the hedge fund industry! This is not an ad, but let’s take a brief look at what statistics has to say about...
Tang Capital Management Discloses Moves into La Jolla Pharmaceutical Company (LJPCD), Vanda Pharmaceuticals Inc. (VNDA), Mirati Therapeutics Inc. (MRTX) & Others
Tang Capital Management, led by Kevin C. Tang, revealed in a filing several moves that have impacted its equity portfolio.
Philip Hempleman, Ardsley Partners Initiate Position in Supernus Pharmaceuticals Inc (SUPN)
Philip Hempleman has become a fan of Supernus Pharmaceuticals Inc (NASDAQ:SUPN).
Orchard Hill Reports a 10% Stake in Supernus Pharmaceuticals
Orchard Hill, Supernus Pharmaceuticals: Earlier this year, Orchard Hill Capital Management purchased a position in Supernus Pharmaceuticals Inc (NASDAQ:SUPN) which contained...
Hi-Tech Pharmacal Co. (HITK): Hedge Funds Aren’t Crazy About It, Insider Sentiment Unchanged
To the average investor, there are tons of gauges investors can use to monitor stocks. A duo of the best are hedge fund and insider trading activity.
Big Movers News: Biodel Inc (BIOD)’s Big News, Supernus Pharmaceuticals Inc (SUPN)’s Spike
Biodel had its price target increased by JMP Securities from $6.00 to $9.00 in a research report sent to investors on Thursday morning, StockRatingsNetwork.com reports.
Is Supernus Pharmaceuticals Inc (SUPN) Going to Burn These Hedge Funds?
To most shareholders, hedge funds are perceived as slow, outdated investment vehicles of yesteryear.
Hedge Funds Aren’t Crazy About Hi-Tech Pharmacal Co. (HITK) Anymore
In the 21st century investor’s toolkit, there are tons of indicators shareholders can use to monitor stocks.
Hedge Funds Are Betting On Supernus Pharmaceuticals Inc (SUPN)
In the 21st century investor’s toolkit, there are dozens of metrics investors can use to watch stocks.
